Workflow
Vertex(VERX)
icon
Search documents
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More
Seeking Alpha· 2025-08-18 13:01
Some tickers are covered more than others on the site, so with The Undercovered Dozen our Editors highlight twelve actionable investment ideas on tickers with less coverage. These ideas can range from "boring" large caps to promising up-and-coming small caps. Specifically, the inclusion criteria for "undercovered" include: market cap greater than $100 million, more than 800 symbol page views in the last 90 days on Seeking Alpha, and fewer than two articles published in the past 30 days. Follow this account ...
Vertex Inc.: Moving To The Sidelines As Near-Term Growth Expectations Get Reset
Seeking Alpha· 2025-08-15 10:50
My previous investment thought on Vertex Inc. (NASDAQ: VERX ) was an upgrade to a buy rating because the growth drivers were intact andthe valuation was also at a more reasonable level. However, 2Q25I focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimately, I aim to ...
Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet
Seeking Alpha· 2025-08-12 18:34
When I last wrote about the biotech stock Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) a month ago, its price had declined by ~20%. This is exactly the extent of correction I had forecast for it, but with a difference. I had expected the decline toManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. ...
Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)
Seeking Alpha· 2025-08-11 20:47
Core Insights - Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has been previously analyzed, indicating a consistent interest in the company's performance and potential [1] - The author emphasizes the importance of patient investing and the accumulation of high-quality assets, suggesting a long-term investment strategy [1] Company Overview - Vertex Pharmaceuticals is recognized for its commitment to improving the world through its business practices, aligning with ethical investment principles [1] - The company is involved in transformative technologies, which may present high-risk, high-reward investment opportunities [1] Investment Philosophy - The investment approach combines steady accumulation of quality assets with opportunities in underappreciated turnaround plays [1] - The author advocates for dividend reinvesting as a method to enhance wealth creation over time [1]
Vertex(VERX) - 2025 Q2 - Quarterly Report
2025-08-06 20:36
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39413 VERTEX, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 23-2081753 ...
Vertex(VERX) - 2025 Q2 - Earnings Call Transcript
2025-08-06 13:32
Vertex (VERX) Q2 2025 Earnings Call August 06, 2025 08:30 AM ET Company ParticipantsJoe Crivelli - VP - IRDavid DeStefano - President, CEO & Chairperson of the BoardJohn Schwab - CFOAdam Hotchkiss - VP - Emerging Software Equity ResearchAlexander Sklar - Vice PresidentConference Call ParticipantsChris Quintero - VP & Equity Research AnalystGeorge Kurosawa - Equity Research AnalystJoshua Reilly - Senior AnalystRob Oliver - Senior Research AnalystAndrew Degasperi - Director & Senior Software AnalystBrent Brac ...
Vertex(VERX) - 2025 Q2 - Earnings Call Transcript
2025-08-06 13:30
Financial Data and Key Metrics Changes - For Q2 2025, revenue was $184.6 million, up 14.6% year over year, with subscription revenue growing 15.7% and cloud revenue increasing by 29.9% [5][26] - Adjusted EBITDA rose to $38.4 million, representing an EBITDA margin of 20.8% [5][30] - Annual recurring revenue (ARR) grew 16.1% to $636.6 million, with average annual revenue per customer increasing 12.7% to $142.6 thousand [5][27] - Gross revenue retention (GRR) remained at 95%, while net revenue retention (NRR) decreased to 108%, down from 109% in Q1 2025 [6][28] Business Line Data and Key Metrics Changes - Subscription revenue increased to $157.8 million, while services revenue grew 8.3% to $26.7 million [27] - Cloud revenue was $86.2 million, up 29.9% year over year, with Ecosio contributing $3.4 million to revenue [27] - Ecosio's ARR reached $10.8 million, a 33% increase from the prior quarter [13][27] Market Data and Key Metrics Changes - The company noted a slowdown in ERP migrations, elongating deal cycles and impacting pipeline build [6][7] - In Europe, there was strong momentum driven by the upcoming e-invoicing mandates, particularly in Belgium, France, and Germany [13][20] Company Strategy and Development Direction - The company is focused on leveraging cloud ERP upgrade cycles and addressing regulatory changes globally to drive growth [8][11] - Investments in AI and e-invoicing solutions are prioritized to enhance customer experience and operational efficiency [15][16] - The company aims to maintain a strong position in the enterprise market, with a focus on expanding its global compliance platform [14][20] Management's Comments on Operating Environment and Future Outlook - Management acknowledged macroeconomic factors impacting customer activity and necessitating a reduction in full-year guidance [4][6] - Despite short-term challenges, management remains confident in long-term growth drivers, including e-invoicing and cloud migrations [8][48] - The company is taking steps to control expenses and improve adjusted EBITDA margins while focusing on long-term strategic goals [7][25] Other Important Information - The company ended Q2 2025 with over $284.4 million in unrestricted cash and cash equivalents, along with $300 million of unused availability under its line of credit [31] - Guidance for Q3 2025 expects revenues of $190 million to $193 million and adjusted EBITDA of $38 million to $40 million [32] Q&A Session Summary Question: Impact of macro factors on guidance - Management indicated that the macro impact primarily affects entitlements and deal activity, leading to a cautious revenue outlook [36][37] Question: E-invoicing adoption rates - Management noted that the end-to-end offering is differentiating and that early customers are expanding their coverage, indicating strong adoption [40][41] Question: Long-term growth outlook - Management remains confident in long-term growth despite short-term deceleration, citing strong regulatory tailwinds and customer durability [46][48] Question: Changes in hiring plans - Management is adjusting hiring plans to focus on strategic areas while leveraging internal efficiencies [49][50] Question: Progression of the quarter - Management observed a strong start in Q1, but noted softness in May and June, impacting deal cycles [55][56] Question: SAP deal activity - Management indicated that uncertainty in the macro environment is causing delays in cloud transformation decisions among customers [57][58] Question: E-invoicing opportunities in Europe - Management highlighted the competitive landscape and the importance of being a single provider across multiple jurisdictions [99][100]
Vertex (VERX) Q2 Earnings and Revenues Surpass Estimates
ZACKS· 2025-08-06 13:21
Vertex (VERX) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.14%. A quarter ago, it was expected that this company would post earnings of $0.13 per share when it actually produced earnings of $0.15, delivering a surprise of +15.38%.Over the last four quarters, the company has surp ...
Vertex(VERX) - 2025 Q2 - Quarterly Results
2025-08-06 11:20
KING OF PRUSSIA, PA – August 6, 2025: Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results for its second quarter ended June 30, 2025. "This quarter's results were in line with expectations, with double-digit revenue growth and healthy profitability and cash flow," said David DeStefano, Vertex's President, Chief Executive Officer and Chairperson of the Board. "We continue to be optimistic about the future for Vertex. ...
Vertex Announces Second Quarter 2025 Financial Results
Globenewswire· 2025-08-06 11:05
Core Viewpoint - Vertex, Inc. reported strong financial results for Q2 2025, with double-digit revenue growth and healthy profitability, despite challenges in contract signings due to extended sales cycles and delayed customer decision-making [2][4]. Financial Performance - Total revenues reached $184.6 million, reflecting a year-over-year increase of 14.6% [5]. - Software subscription revenues amounted to $157.8 million, up 15.7% year-over-year [5]. - Cloud revenues grew significantly by 29.9% to $86.2 million [5]. - Annual Recurring Revenue (ARR) was $636.6 million, a 16.1% increase year-over-year, with a 14.1% growth excluding the impact of the ecosio acquisition [5]. - Average Annual Revenue per direct customer (AARPC) increased to $130,934 from $123,570 a year ago [5]. - Net Revenue Retention (NRR) was 108%, slightly down from 110% a year ago [5]. - Gross Revenue Retention (GRR) remained stable at 95% [5]. Profitability Metrics - The company reported a loss from operations of $3.9 million, compared to an income of $7.5 million in the same period last year [5]. - Non-GAAP operating income was $32.2 million, down from $33.3 million year-over-year [5]. - Net loss was $1.0 million, compared to a net income of $5.2 million in the prior year [5]. - Non-GAAP net income stood at $24.9 million, with diluted earnings per share (EPS) of $0.15 [5]. Financial Outlook - For Q3 2025, Vertex expects revenues between $190.0 million and $193.0 million, and Adjusted EBITDA between $38.0 million and $40.0 million [6]. - The full-year 2025 revenue guidance has been reduced due to the impact of delayed contract signings [4][6]. Customer Metrics - The total number of direct customers was 4,862 as of June 30, 2025, showing a slight decrease from the previous quarter [20]. - Indirect customers increased to 504, up from 481 in the previous quarter [20]. Cash Flow and Liquidity - Cash and cash equivalents were reported at $284.4 million as of June 30, 2025 [26]. - The company generated net cash provided by operating activities of $60.8 million [32]. Strategic Insights - The company remains optimistic about future growth driven by increasing complexity in indirect taxes and the ongoing shift to ERP cloud conversions and e-invoicing mandates [2].